FITLIFE BRANDS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
FITLIFE BRANDS, INC. (FTLF) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $1.73 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-31
- FITLIFE BRANDS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $1.73M, a 35.16% decline from fiscal 2024.
- FITLIFE BRANDS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $2.67M, a 70.81% increase from fiscal 2023.
- FITLIFE BRANDS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $1.56M, a 11.81% increase from fiscal 2022.
- FITLIFE BRANDS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $1.40M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $1.73M 10-K · filed 2026-03-31 |
| 2024-12-31 | $2.67M 10-K · filed 2026-03-31 |
| 2023-12-31 | $1.56M 10-K · filed 2025-03-27 |
| 2022-12-31 | $1.40M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |